No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Antoinette Hollestelle, Frederieke H. van der Baan, Andrew Berchuck, Sharon E. Johnatty, Katja K. Aben, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Antonis C. Antoniou, Carmel Apicella, Volker Arndt, Norbert Arnold, Banu K. Arun, Brita Arver, Alan Ashworth, Laura Baglietto, Rosemary BalleineElisa V. Bandera, Daniel Barrowdale, Yukie T. Bean, Lars Beckmann, Matthias W. Beckmann, Javier Benitez, Andreas Berger, Raanan Berger, Benoit Beuselinck, Maria Bisogna, Line Bjorge, Carl Blomqvist, Natalia V. Bogdanova, Anders Bojesen, Stig E. Bojesen, Manjeet K. Bolla, Bernardo Bonanni, Judith S. Brand, Hiltrud Brauch, Hermann Brenner, Louise Brinton, Angela Brooks-Wilson, Fiona Bruinsma, Joan Brunet, Thomas Bruning, Ralf Butzow, Arto Leminen, Taru A. Muranen, Heli Nevanlinna, Liisa M. Pelttari, Ovarian Canc Assoc Consortium, Breast Canc Assoc Consortium, Consortium Modifiers BRCA1 & BRCA2, Australian Ovarian Canc Study Grp, Breast Cancer Family Register, EMBRACE, GEMO Study Collaborators, GENICA Network, HEBON, KConFab Investigators, SWE-BRCA

Research output: Contribution to journalReview ArticleScientificpeer-review

Original languageEnglish
JournalGynecologic Oncology
Volume141
Issue number2
Pages (from-to)386-401
Number of pages16
ISSN0090-8258
DOIs
Publication statusPublished - May 2016
MoE publication typeA2 Review article in a scientific journal

Fields of Science

  • KRAS variant
  • Breast cancer
  • Ovarian cancer
  • Genetic association
  • Clinical outcome
  • GENOME-WIDE ASSOCIATION
  • MICRORNA-BINDING-SITE
  • SUSCEPTIBILITY LOCI
  • RISK
  • PROSTATE
  • IDENTIFICATION
  • POLYMORPHISMS
  • ENDOMETRIOSIS
  • WOMEN
  • 3123 Gynaecology and paediatrics
  • 3122 Cancers

Cite this